Arterra Bioscience SpA ARBS

MIL · Italy · Health Technology

€3.06-0.02 (-0.65%)

Market open· Oct 1, 2026, 10:18 AM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Arterra Bioscience SpA ARBS

MIL · Italy · Health Technology

€3.06-0.02 (-0.65%)

Market open· Oct 1, 2026, 10:18 AM UTC· EUR · Data may be delayed

+2.00% · 6MFull-screen chart

Open €3.03High €3.06Low €3.02Close €3.06Volume 3.00K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €3.08
Day range: €3.02 – €3.06
52-week range: €2.60 – €3.58
Volume: 3.00K
Market cap: €20.51M
Dividend yield (annualized): 4.92%
Next earnings date: 2027-03-03
Avg. volume (1Y): 16.05K

Performance

1 week

-1.92%

1 month

-0.97%

3 months

-4.38%

6 months

+3.10%

Year to date

+5.12%

1 year

+17.40%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Italy
Exchange: MIL
Shares outstanding: 6.66M
ISIN: IT0005386369
Beta: 0.61

Technical view

Details →

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Details →

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

Prices may be delayed and are for informational purposes only - not investment advice.

+2.00% · 6MFull-screen chart

Open €3.03High €3.06Low €3.02Close €3.06Volume 3.00K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €3.08
Day range: €3.02 – €3.06
52-week range: €2.60 – €3.58
Volume: 3.00K
Market cap: €20.51M
Dividend yield (annualized): 4.92%
Next earnings date: 2027-03-03
Avg. volume (1Y): 16.05K

Performance

1 week

-1.92%

1 month

-0.97%

3 months

-4.38%

6 months

+3.10%

Year to date

+5.12%

1 year

+17.40%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Italy
Exchange: MIL
Shares outstanding: 6.66M
ISIN: IT0005386369
Beta: 0.61

Technical view

Details →

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Details →

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.